Literature DB >> 14832215

The inhibition of tobacco mosaic virus by synthetic lysine polypeptides.

M A STAHMANN, L H GRAF, E L PATTERSON, J C WALKER, D W WATSON.   

Abstract

Entities:  

Keywords:  LYSINE; TOBACCO MOSAIC VIRUS

Mesh:

Substances:

Year:  1951        PMID: 14832215

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  8 in total

1.  The action of poly-lysine on the conversion of fibrinogen into fibrin by coagulase thrombin.

Authors:  N BIEZUNSKI; E SHAFRIR; A DE VRIES; E KATCHALSKI
Journal:  Biochem J       Date:  1955-01       Impact factor: 3.857

2.  The action of trypsin on polylysine.

Authors:  S G WALEY; J WATSON
Journal:  Biochem J       Date:  1953-09       Impact factor: 3.857

3.  A method for preparation of antibacterial basic proteins of normal tissues.

Authors:  W L BLOOM; J R PRIGMORE
Journal:  J Bacteriol       Date:  1952-12       Impact factor: 3.490

4.  The inhibition of two antibacterial basic proteins by nucleic acids.

Authors:  W L BLOOM; M G WINTERS; D W WATSON
Journal:  J Bacteriol       Date:  1951-07       Impact factor: 3.490

5.  Antineoplastic activity of poly(L-lysine) with some ascites tumor cells.

Authors:  L J Arnold; A Dagan; J Gutheil; N O Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

6.  Poly-L-Lysine Inhibits Tumor Angiogenesis and Induces Apoptosis in Ehrlich Ascites Carcinoma and in Sarcoma S-180 Tumor

Authors:  Souvik Debnath; Saumen Karan; Manish Debnath; Jyotirmayee Dash; Tapan Kumar Chatterjee
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27

Review 7.  The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides.

Authors:  Traian V Chirila; Piroska E Rakoczy; Kerryn L Garrett; Xia Lou; Ian J Constable
Journal:  Biomaterials       Date:  2002-01       Impact factor: 12.479

Review 8.  Broad-Spectrum Antiviral Agents Based on Multivalent Inhibitors of Viral Infectivity.

Authors:  Alexander N Zelikin; Francesco Stellacci
Journal:  Adv Healthc Mater       Date:  2021-01-25       Impact factor: 9.933

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.